Zinc finger factor ZNF121 is a MYC-interacting protein functionally affecting MYC and cell proliferation in epithelial cells

a.
Department of Genetics and Cell Biology, Nankai University College of Life Sciences, Tianjin 300071, China
b.
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA

More Information

Corresponding author: E-mail address: j.dong@emory.edu (Jin-Tang Dong)

摘要

- /
- /
Abstract: MYC is a potent oncoprotein that modulates multiple cellular processes including proliferation, apoptosis, differentiation, stemness, senescence, and migration. Functioning primarily as a transcriptional factor, MYC interacts with a large number of proteins, and identification and characterization of MYC-interacting proteins are important for understanding how MYC functions. In this study, we used different systems to demonstrate that a novel zinc finger transcription factor, ZNF121, physically interacted with MYC, and the interaction involved their N-terminal regions. Overexpression of ZNF121 increased, while its knockdown decreased, the expression of MYC in multiple epithelial cell lines, and MYC had similar effects on ZNF121 expression. An expression correlation was also detectable in a panel of epithelial cell lines and a cohort of human breast cancer tissues. Functionally, knockdown ofZNF121 in several breast epithelial cell lines attenuated the expressions of MYC and its target genes (e.g., EGR1, CDC2, and nucleolin) and slowed cell proliferation, accompanied by cell cycle arrest in the G1 phase and expression alteration of cell cycle regulators (cyclin D1, p14 and p21). Analysis of publically available databases showed that ZNF121 expression is up-regulated in human breast cancer, and the up-regulation significantly associates with worse patient survival in the luminal A subtype of breast cancer. These findings establish ZNF121 as a MYC-interacting protein with functional effects on MYC and cell proliferation.
- ZNF121 /
- MYC /
- Cell proliferation

HTML全文

参考文献(26)

[1]	Agrawal, P., Yu, K., Salomon, A.R. et al. Proteomic profiling of Myc-associated proteins Cell Cycle, 9 (2010),pp. 4908-4921
[2]	Bierne, H., Tham, T.N., Batsche, E. et al. Human BAHD1 promotes heterochromatic gene silencing Proc. Natl. Acad. Sci. U. S. A., 106 (2009),pp. 13826-13831
[3]	Brandenberger, R., Wei, H., Zhang, S. et al. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation Nat. Biotechnol., 22 (2004),pp. 707-716
[4]	Chen, H., Kalaitsidaki, M., Warren, A.C. et al. Genomics, 15 (1993),pp. 621-625
[5]	Correa, S., Pizzatti, L., Du Rocher, B. et al. A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line Proteome Sci., 10 (2012),p. 23
[6]	Curtis, C., Shah, S.P., Chin, S.F. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Nature, 486 (2012),pp. 346-352
[7]	Dang, C.V. MYC on the path to cancer Cell, 149 (2012),pp. 22-35
[8]	Gao, J., Aksoy, B.A., Dogrusoz, U. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal Sci. Signal., 6 (2013)
[9]	Hungermann, D., Schmidt, H., Natrajan, R. et al. Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer J. Pathol., 224 (2011),pp. 517-528
[10]	Koch, H.B., Zhang, R., Verdoodt, B. et al. Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach Cell Cycle, 6 (2007),pp. 205-217
[11]	Li, X., Zhang, B., Wu, Q. et al. Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells Int. J. Cancer, 136 (2015),pp. 536-546
[12]	Liu, H., Radisky, D.C., Yang, D. et al. MYC suppresses cancer metastasis by direct transcriptional silencing of alphav and beta3 integrin subunits Nat. Cell Biol., 14 (2012),pp. 567-574
[13]	Liu, J., Levens, D. Making myc Curr. Top. Microbiol. Immunol., 302 (2006),pp. 1-32
[14]	Lutz, W., Leon, J., Eilers, M. Contributions of Myc to tumorigenesis Biochim. Biophys. Acta, 1602 (2002),pp. 61-71
[15]	Madden, S.F., Clarke, C., Gaule, P. et al. BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome Breast Cancer Res., 15 (2013),p. R52
[16]	Meyer, N., Penn, L.Z. Reflecting on 25 years with MYC Nat. Rev. Cancer, 8 (2008),pp. 976-990
[17]	Paul, I., Ahmed, S.F., Bhowmik, A. et al. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity Oncogene, 32 (2013),pp. 1284-1295
[18]	Popov, N., Wanzel, M., Madiredjo, M. et al. The ubiquitin-specific protease USP28 is required for MYC stability Nat. Cell Biol., 9 (2007),pp. 765-774
[19]	Takahashi, K., Tanabe, K., Ohnuki, M. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell, 131 (2007),pp. 861-872
[20]	Tang, S.W., Chang, W.H., Su, Y.C. et al. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells Cancer Lett., 273 (2009),pp. 35-43
[21]	Tansey, W.P. Mammalian MYC proteins and cancer New J. Sci., 2014 (2014),p. 757534
[22]	Thomas, L.R., Tansey, W.P. Proteolytic control of the oncoprotein transcription factor Myc Adv. Cancer Res., 110 (2011),pp. 77-106
[23]	Tu, W.B., Helander, S., Pilstal, R. et al. Myc and its interactors take shape Biochim. Biophys. Acta, 1849 (2015),pp. 469-483
[24]	Woods, N.T., Mesquita, R.D., Sweet, M. et al. Charting the landscape of tandem BRCT domain-mediated protein interactions Sci. Signal., 5 (2012)
[25]	Xu, J., Chen, Y., Olopade, O.I. MYC and breast cancer Genes Cancer, 1 (2010),pp. 629-640
[26]	Zhang, Q., Spears, E., Boone, D.N. et al. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity Proc. Natl. Acad. Sci. U. S. A., 110 (2013),pp. 978-983